Precision Medicine and Diagnostics

(1030-C) A continuous kinetic assay to quantitate specific protein kinase activity in unfractionated cell lysates

(1049-B) Fully-Automated Extraction of High-Quality Total Nucleic Acids from FFPE specimens using Covaris® truXTRAC® FFPE SMART Solutions and Hamilton Robotics

(1080-A) NanoBeacon.AI: AI-enhanced nanodiamond biosensor for automated sensitivity prediction to oxidative phosphorylation inhibitors

(1082-C) Automating cell-free and formalin-fixed paraffin-embedded DNA library preparation for Next Generation Sequencing workflows on the Biomek® NGeniuS® System

(1083-D) Implementation of Laboratory Automation to Support Scaling of Cancer Patients Testing using OmniSeq® INSIGHT Molecular Diagnostic Test

(1088-A) Optimization of DNA methyltransferase inhibitors-based combination through quadratic phenotypic optimization platform (QPOP) to target the epigenome of gastric cancer

(1120-A) Using a high-throughput drug optimization platform to optimize patient-specific drug treatments for aortic valve stenosis

(1134-C) Automated Tissue Dissection Solution to Support Comprehensive Genomic and Immune Profiling

(1135-D) Establishment of a quality-driven manufacturing process to reprogram human donor material into human induced pluripotent stem cells to support drug discovery.

(1359-D) Porosome Therapeutics Inc., has Developed Therapy to Rescue Cystic Fibrosis by Reprogramming the Porosome Secretory Machinery